10.1016/S0896-6273(00)80405-5
10.1016/S0968-0004(98)01350-4
10.1523/JNEUROSCI.20-19-07268.2000
10.1016/S0896-6273(01)00177-5
10.1016/S0092-8674(00)80513-9
10.1016/S0140-6736(03)13304-1
10.1016/S0092-8674(00)81781-X
10.1016/S0092-8674(00)81782-1
10.1016/S0962-8924(00)01852-3
10.1016/S0896-6273(02)00761-4
10.1016/S0140-6736(05)78898-X
10.1016/S0896-6273(00)81004-1
10.1111/j.1750-3639.1999.tb00216.x
10.1046/j.1471-4159.2001.00689.x
10.2165/00002512-200118090-00004
10.1002/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K
Sokolov S, 2006, Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers, Biochim Biophys Acta, 12, 12
10.1111/j.1742-4658.2006.05318.x
Perluigi M, 2005, Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice − a model of Huntington's disease, Mol Cell Proteomics, 20, 20
10.1016/S0003-9861(02)00585-4
10.1016/j.abb.2003.08.028
10.1016/S0014-5793(03)00353-3
10.1016/S0047-6374(00)00124-X
10.1097/00002093-200000001-00010
10.1016/S0891-5849(01)00513-5
10.1016/S0891-5849(02)00801-8
10.1016/S0304-3940(02)01254-5
10.1016/S0005-2728(98)00114-5
10.1080/152165401317291156
10.1016/j.ymeth.2004.08.003
10.1016/j.biocel.2006.02.006
Sayre LM, 2000, The role of metals in neurodegenerative diseases, Cell Mol Biol, 46, 731
Fernandes Leite J, 2001, Huntington s disease: a bimolecular vision, Rev Neurol, 32, 762
10.1016/S0891-5849(01)00510-X
10.1016/S1097-2765(04)00151-0
Diaz‐Hernandez M, 2006, Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain, J Neurochem, 19, 19
10.1128/MCB.22.3.816-834.2002
10.1523/JNEUROSCI.22-21-09267.2002
10.1016/S0076-6879(94)33040-9